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Next generation sequencing (NGS) is currently being adapted by different biotechnological platforms to the standard typing
method forHLA polymorphism, the huge diversity of which makes this initiative particularly challenging. Boosting the molecular
characterization of the HLA genes through efficient, rapid, and low-cost technologies is expected to amplify the success of tissue
transplantation by enabling us to find donor-recipient matching for rare phenotypes. But the application of NGS technologies
to the molecular mapping of the MHC region also anticipates essential changes in population genetic studies. Huge amounts of
HLA sequence data will be available in the next years for different populations, with the potential to change our understanding of
HLA variation in humans. In this review, we first explain how HLA sequencing allows a better assessment of the HLA diversity in
human populations, taking also into account the methodological difficulties it introduces at the statistical level; secondly, we show
how analyzing HLA sequence variation may improve our comprehension of population genetic relationships by facilitating the
identification of demographic events that marked human evolution; finally, we discuss the interest of both HLA and genome-wide
sequencing and genotyping in detecting functionally significant SNPs in the MHC region, the latter having also contributed to the
makeup of the HLAmolecular diversity observed today.
1. Introduction
About four decades ago, when HLA-typed population sam-
ples fromdifferent geographic locations started to be available
for comparative analyses, both allele frequencies and link-
age disequilibrium measures revealed extensive geographic
variation (e.g., [1–4] for Europe). These patterns were inter-
preted as explicit signals of human migration history, based
on which impressive syntheses on “classical” polymorphic
markers were published [5]. At the time of these studies,
however, a very limited part of the HLA polymorphism was
described as it merely consisted of a few dozens of alleles at
three main genes (A, B, and DRB1). As the number of known
alleles increased thanks to the development of powerful
molecular technology, to a growing interest in anthropology
within the frame of international histocompatibility and
immunogenetics workshops [6–11], and to continuous efforts
of transplantation laboratories to type potential bonemarrow
donors, the overall picture became more complex: above all,
distinctive sets of alleles, as well as unusual frequencies of
a “blank” (i.e., the sum of frequencies of putative unknown
alleles), were observed in different populations, raising new
challenges to the estimation of genetic distances and other
useful statistics. In parallel, an important role of natural selec-
tion in shaping the patterns of HLA diversity became visible
in the form of both a significant excess of heterozygosity in
most populations and an excess of nonsynonymous polymor-
phism within HLA loci. Such results provided evidence that
the immunological function within HLA genes was a target
of balancing selection (see [12] for a review). An increasing
number of associations, both positive and negative, between
HLA alleles and diseases were also proposed (reviewed in
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[13]), the results being often heterogeneous across studies
and/or populations. Last but not least, the finding of interac-
tions betweenHLA and other highly polymorphic molecules
of the immune system, such as KIR, raised the possibility of
immune-mediated coevolution betweenHLA and other gene
families [14].
As described above, in the last decades not only has the
HLA polymorphism become very hard to describe in human
populations, due to its molecular complexity, but also its
interpretation turned out to be much more challenging
in view of the intricate mechanisms driving its evolution.
Fortunately, the development of constantly updated reposi-
tories of allele definitions [15], of powerful biostatistical tools
taking into account typing ambiguities to analyze genetic
diversity [10, 16], and of large databases of HLA frequencies
in populations from all over the world [17–19] simplified the
analysis of these data. As a result, new studies confirmed
the important role played by geography and demographic
history in the evolution of theHLA polymorphism inmodern
humans, for example, in Europe [20], and allowed better
assessments of natural selection acting on the different HLA
genes [19, 21–24]. On the other hand, these works are still
based on a partial description of the molecular variation in
the MHC region.
Now next generation sequencing (NGS) may fill this
gap. Although this technology is not yet applied to HLA
in routine practice due to methodological, mainly bioinfor-
matics, complications [25], large amounts of HLA sequence
data will be available in the next few years for population
genetic studies. In this review, we first explain how using
DNA sequence data will improve the assessment ofHLA pop-
ulation diversity compared to the present situation; we then
show how different methods adapted to these data will help
in reconstructing the evolution of modern humans taking
into account both demography and natural selection. Finally,
we discuss how bothHLA and genome-wide sequencing will
lead to the detection of functionally important polymorphic
sites in the MHC region, with crucial implications in popu-
lation genetics. Overall, these approaches will provide a bet-
ter comprehension of themolecular evolution of this amazing
polymorphism.
2. Improving the Assessment of Population
Diversity through HLA Sequencing
The genetic profile of a given population is generally
described by a number of observed alleles to which relative
frequencies are assigned. Such a distribution is currently
inferred from a list of possible genotypes deduced from the
molecular typing of a sample of individuals representative of
this population. However, so far the HLA typing techniques
most commonly used in routine practice (PCR-SSOand SSP),
while being very useful for clinical purposes, only capture a
part of the molecular information and generate a lot of ambi-
guities. Hence, genetic studies aiming at comparing human
populations are constrained to use frequencies ofHLA alleles
defined nominally at the first and second fields of the HLA
nomenclature (IMGT/HLA database [15]). These first two
sets of digits used to name alleles correspond, respectively, to
allele groups and specific protein-coding alleles, both of them
being principally defined at the peptide-binding region (PBR)
of the HLA molecule. Now NGS applied to HLA genes will
allow taking into account the molecular distances between
alleles in terms of nucleotide differences (which were not
considered with alleles defined nominally), the molecular
variation due to synonymous substitutions in the coding
regions (the third set of digits in theHLA nomenclature), and
the molecular variation due to substitutions in noncoding
regions, that is, introns and 3󸀠–5󸀠 untranslated (UTR) regions
flanking exons and introns (the fourth set of digits in the
HLA nomenclature). In this section, we explain how this new
material may improve the assessment of population diversity.
2.1. Molecular Distances between HLA Alleles. HLA alleles
may differ from each other by one tomultiple nucleotide sub-
stitutions, the range of which depends on the locus. Taking
the whole set of alleles observed in a given population sample
and their frequencies, a fine description of the totalmolecular
diversity of this sample can be represented by the distribution
of pairwise nucleotide differences among these alleles, named
“mismatch distribution.” Mismatch distributions plotted for
56–106 human populations based on HLA alleles defined at
the second field of the HLA nomenclature [21] for different
loci revealed different shapes between some populations (the
meaning of which is discussed below) but also very large
variances; this indicates that in addition to high numbers of
alleles found at different frequencies all human populations
carry sets of alleles that exhibit a very large spectrum of
molecular distances between them.
Interestingly, this molecular information can be taken
into account to compute genetic distances among popula-
tions. For example, the commonly used Reynold’s genetic
distances [26], which is usually derived from a 𝐹st index [27]
based on allele frequencies, can also be computed from a Φst
index [28] based on both allele frequencies and themolecular
distances between alleles. As illustrated in Figure 1, Φst-
derived distances may deviate to a large extent from more
classical 𝐹st-derived genetic distances, suggesting that the
introduction of HLA sequence information (even though
limited to nonsynonymous substitutions in the given exam-
ple) may substantially change our assessment of population
relationships.
2.2. Synonymous and Nonsynonymous Substitutions. Taking
into account synonymous substitutions (the third field of
the HLA nomenclature) may provide even more detailed
estimates of genetic relatedness between populations, despite
the fact that they are of limited interest for transplantation.
The proportion of nonsynonymous is known to exceed that
of synonymous substitutions in the PBR (providing evidence
of balancing selection) [29–31], but the number of known
synonymous substitutions is also becoming quite substantial.
Although the number of alleles defined by such silent muta-
tions (i.e., the third field alleles) is still limited (Table 1), many
of them are detected in population samples typed by high-
throughput sequencing (e.g., [32]). Actually, this may even
change to a large extent the overall HLA allele repertoire:
among the 2127 new HLA-A, -B, and -C alleles recently
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Table 1: Number (#) and proportion (%) of HLA alleles defined at the second, third, and fourth fields of the current HLA nomenclature
(IMGT/HLA database release 3.15.0, 2014-01-17). The third field (highlighted in bold) is defined by synonymous nucleotide substitutions in
coding regions.
Locus Total Second field Third field Fourth field
# # % # % # %
A 2579 1862 72.2% 691 26.8% 26 1.0%
B 3285 2404 73.2% 858 26.1% 23 0.7%
C 2133 1486 69.7% 616 28.9% 31 1.5%
DRA 7 0 0.0% 4 57.1% 3 42.9%
DRB1 1411 972 68.9% 429 30.4% 10 0.7%
DQA1 51 23 45.1% 13 25.5% 15 29.4%
DQB1 509 318 62.5% 181 35.6% 10 2.0%
DPA1 37 15 40.5% 17 45.9% 5 13.5%
DPB1 248 198 79.8% 46 18.5% 4 1.6%
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Figure 1: Plot comparisons of two differentmeasures of genetic distances among populations. Each point corresponds to a pair of populations
(taken from a large database of 90 populations typed for HLA-B and 106 populations typed for HLA-DRB1, resp.) for which two values are
reported: the genetic distance estimated by taking into account both the allele frequencies and the molecular distance between the alleles
(“Φst-derived” Reynold’s genetic distance based on PBR sequences, 𝑋 axis) and the genetic distance estimated only from allele frequencies
(“𝐹st-derived” Reynolds’ genetic distance based on allele frequencies,𝑌 axis). (a) LocusHLA-B; in this plot, the population pairs formed by the
Samoans and all other populations are highlighted by red squares. (b) HLA-DRB1; in this plot, the population pairs formed by the Lebanese
Arabs and all other populations are highlighted by red squares. For Samoans at HLA-B, genetic distances are clearly skewed toward higher
values with Reynold’s genetic distance based on PBR sequences, while the opposite situation is observed for the Lebanese Arabs atHLA-DRB1.
Taking into account the molecular information has thus substantial effects on the estimation of population relationships (from [21]).
discovered by SBT sequencing in a large set of potential
haematopoietic stem cell donors from Germany, United
States, and Poland [33], as many as 28–30% of them were
defined by synonymous substitutions. This suggests that
a significant portion of silent HLA polymorphism, so far
neglected in population genetics studies, may be relevant
to infer geographic and/or historical relationships between
populations. A special interest, here, is that synonymous
substitutions aremore prone to evolve neutrally than nonsyn-
onymous substitutions, in particular when the latter occur in
functionally important regions of the molecule like the PBR.
Unless hitchhiked by neighboring polymorphic sites strongly
submitted to selection (which may often happen, of course),
the frequency of such (a priori) neutral polymorphisms
fluctuates by random genetic drift and other mechanisms
related to the demography of populations, such as gene flow
and long-rangemigration.Thedetermination of synonymous
variants in the HLA region may thus be very informative to
study this polymorphism in relation to the history of human
populations.
2.3. Variation outside the Exons Coding for the PBR. As
mentioned above, so far the HLA data used in population
genetics studies did not take into accountmolecular variation
outside the exons coding for the PBR, that is, other exons
as well as introns and 3󸀠–5󸀠 UTR regions flanking exons
and introns (the fourth field of the HLA nomenclature),
except in some recent studies [34]. Although a huge part
of the HLA molecular variation is concentrated in the PBR-
coding exons, polymorphic sites are however distributed all
4 Journal of Immunology Research
along the 4Mb HLA super-locus [35], and other exons as
well as introns sometimes reveal important variation (e.g.,
8 intronic substitutions and variation in exon 1 distinguish
A∗74 : 01 and A∗74 : 02 : 01, [36]). High-throughput HLA
sequencing, if applied systematically to population samples
from different geographic locations, is thus expected to reveal
a large amount of polymorphism outside the traditionally
tested exons 2 and 3. The main interest is that many of these
sites may not behave as neutral polymorphisms. Indeed, by
contrast with the “junk-DNA” theory which has prevailed
during the last decades, recent studies suggest that a very
large part of regions previously thought to be in the “junk”
category do in fact have functional roles (see [37], for a
review). Many SNPs located in noncoding portions of the
HLA region might therefore be associated with regulatory
functions, as discussed in more detail below. In addition, due
to the high level of linkage disequilibriumobserved across the
humanMHC [38], background selection (i.e., strong negative
selection against deleterious mutations) or selective sweep
(i.e., strong positive selection in favor of beneficialmutations)
may affect the evolution of neutral polymorphic sites located
at the vicinity of selected mutations (this is also true for syn-
onymous substitutions in the coding regions, as mentioned
above). In this case, the variability of such putatively neutral
sites would not mirror the effects of population demography.
The great advantages of working with HLA sequences is
that it allows addressing these issues with more accuracy
than in the past: first, by testing deviation from neutrality
using methods adapted to DNA sequences (e.g., [39, 40]) for
different portions of the MHC region located either in exons,
in introns, or in 3󸀠–5󸀠 UTR regions and second, by testing
linkage disequilibrium across these regions, thanks to the
putatively nonambiguous reconstruction of haplotype blocks.
These approaches may provide a qualitative assessment, in
terms of evolutionary significance, of the molecular variation
observed in different HLA region, which may then serve to
determine the most appropriate region to retain for further
population genetics studies.
3. Inferring Population Historical
Relationships from HLA Sequence Data
From a molecular point of view,HLA sequencing is expected
to generate very precise information on human genetic
diversity (as explained above) and to provide an abundant
source of information to infer human history. In this section,
we first discuss potential problems and pitfalls linked to the
generation of this new kind of data, and we then examine
some attractive approaches to deal with them.
3.1.The Problem ofMultiplying the Number of HLAAlleles. By
taking into account new potential sources of DNA variability
both within (with synonymous mutations) and outside (with
other exons and with introns and 3󸀠–5󸀠 UTR) the PBR exons,
high-throughput HLA sequencing is expected to increase
very fast the number of observable HLA alleles. So far, the
number of common and well-defined alleles at classicalHLA
loci has already increased more than threefold between the
first two versions of the ASHI catalogue [41, 42]. Moreover,
catalogues based on different population sets do not overlap
completely [43, 44], which predict major allelic booms when
new populations from all over the world are genotyped.
The generalization of NGS to HLA will probably reveal
new common alleles within some known highly frequent
two-field (or three-field) allele groups with distinctive hap-
lotypic associations (e.g., DQA1∗01 : 01 or DQA1∗01 : 02),
which will definitely lead us to revise both our records of
disease-associated alleles or haplotypes and our expectations
regarding donor-recipientmatching in tissue transplantation.
However, many alleles are also expected to be observed as
unique sequences, not only because new variants are likely
to be constantly generated by gene conversion or point
mutations and lost by purifying selection or genetic drift [45],
but also because the chances of detecting identical rare alleles
in population samples of limited size (which is generally the
case in real studies, to the exception of donor registries) are
low. We are thus probably reaching a situation where allele
frequencies, being too small to be accurately estimated if
sample sizes are not massively increased, become unusable in
many population data analyses like those involving the com-
putation of genetic distances among populations (as already
occurs with HLA haplotype frequencies). Also, more quali-
tative measures of population relatedness like allele sharing,
although very attractive [46], are hardly applicable in current
sampling conditions. Unless extensively defined HLA alleles
are recoded to lower levels of resolution, other approaches
have thus to be adopted.
Interestingly, this pattern reflects a feature that has been
observed in genome-wide sequencing studies: as sequence
data probes genetic variation at higher coverage and for larger
samples, the proportion of genetic variants which are very
rare (i.e., restricted to one or very few individuals) becomes
increasingly prevalent. For example, in the exome survey
of the 1000 genomes data, which generated high coverage
sequencing of coding regions, the number of unique variants
increased largely with respect to that seen in previous surveys
[47]. This suggests that a similar trend will be observed for
HLA data, with many novel rare variants being discovered
as sequencing surveys expand. Rare variants play a key role
in contemporary population genetics, since they contribute
substantially to the overall pool, but individually each variant
is rare, making a study of its evolutionary and functional
impacts challenging [48].
3.2. The Pitfall of Gene Trees. In a situation where genetic
diversity is described by many single sequences, one tempta-
tion is the reconstruction of phylogenetic trees, which repre-
sent putative evolutionary relationships between alleles from
their sequence homology. This approach was successfully
applied to human and chimpanzee MHC sequences as it
led to the conclusion that most HLA lineages predate the
divergence of these two species some 7-8 million years ago
([49], recently confirmed by [50]), while HLA alleles are
much more recent [51]. This long persistence time of HLA
lineages was explained by balancing selection [49, 52, 53].
When population genetic studies focusing on human evo-
lution switched from “classical markers” (blood groups,
allozymes, etc.) to DNA-typed polymorphisms, inferences
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Figure 2: Distributions of the number of nucleotide differences between pairs of sequences (mismatch distributions) in two Asiatic
populations of close sample sizes, one Taiwanese (Ami, 𝑁 = 98, top) and one continental (Uyghur, 𝑁 = 105, bottom), based on DNA
sequences of HLA-A, HLA-B, and HLA-DRB1 alleles defined at high resolution (sequences downloaded from IMGT/HLA database). While
the distributions exhibit a likely unimodal shape for the Uyghur, suggesting recent demographic expansion, they are very irregular for the
Ami, reflecting population stationarity or contraction (note that the zero class corresponds to identical sequences, reflecting a high proportion
of homozygosity). Besides these demographic signatures, Tajima’s 𝐷 are positive for all distributions, in agreement with balancing selection
acting on these loci (not shown).
on population history, including the famous Out-of-Africa
hypothesis [54], were also based on phylogenetic trees.
Actually, these approaches introduced a lot of confusion.
First, gene trees are easier to build than to interpret. Not
only can different molecular distances and algorithms be
used to build a tree, but the number of possible trees for
a given set of DNA sequences is excessively large, with the
consequence that the retained final tree is not necessarily the
most robust. To infer the time to the most recent common
ancestor (i.e., the age) of a given allele lineage or of the entire
tree also supposes a “molecular clock,” that is, a constant
mutation rate across successive generations, which is hardly
verified for short evolutionary times, and even less when
complex evolutionary mechanisms (like the shuffling ofHLA
genes by gene conversion) are at work. In addition, the
calibration of the molecular clock needs information on
well-documented fossil remains, which most often does not
exist. But besides all these complications, the principal pitfall
is actually to believe that gene trees reproduce population
trees, when it is not the case [55, 56]. First, each gene has
its own genealogy, generally different from the genealogy
of populations; secondly, genes circulate horizontally across
populations through gene flow,meaning that genetically close
populations may have a geographic, rather than a historical
relationship; thirdly, the age of a given lineage has nothing to
do with the age of a population, genes being generally much
older. Putative evolutionary relationships between HLA alle-
les may sometimes be relevant for population migrations’
history; an example is given by [57], who relates the presence
of DRB1∗08 : 02 : 01 in East Asians and the same allele plus
several of its subtypes in Amerindians to “the founder
migrations from Asia to America through the Bering Strait.”
However, while this example reminds us that rare alleles may
be shared by populations located in geographically distant
regions and may hence represent a possible legacy of their
common ancestry, such interpretations should be taken with
caution when based on observations done on single genes.
3.3. UnderstandingDiversity through the Coalescent Approach.
A main alternative to the phylogenetic approach is to use
coalescent theory [58], which analyzes the relationships
between themolecular diversity of a sample of observedDNA
sequences and their possible genealogy (i.e., the history of
their inheritance across generations, not to be confounded
with a phylogeny). As defined above, the molecular diversity
of a sample of observed DNA sequences can be described
by a “mismatch distribution.” The latter is expected to be
multimodal for populations at demographic equilibrium or
having passed through a recent bottleneck, and unimodal
in case of either demographic or range expansion (i.e., large
spatial dispersal) with high levels of migration between
neighboring populations [59–61]. Figure 2 shows an example
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where mismatch distributions have been obtained at the
HLA-A, -B, and -DRB1 loci for two population samples of
comparable sizes, Central Asian Uyghur and Taiwanese Ami.
Although, in these examples, synonymous mutations are not
taken into account (which underestimates the total diversity),
we note that the shapes of these distributions markedly differ
between the two populations; they are compatible (at the
3 loci) with demographic signals of demographic or range
expansion, for the Uyghur, and with population contraction,
for the Ami, suggesting distinct (and plausible) demographic
histories of these two populations.
However, in molecular evolution different mechanisms
linked either to demographic history or natural selection
sometimes generate similar genetic signals and are thus dif-
ficult to disentangle. This has already been stressed for HLA
[21, 23]. In the case ofmismatch distributions, selective sweep
or purifying selection may mimic the effects of demographic
expansion by generating unimodal shapes (due to an accu-
mulation of low frequency alleles); on the contrary, balancing
selection may mimic the effect of population contraction by
generating multimodal profiles (due to the maintenance of
intermediate frequency alleles). A commonly used statistic
to assess the significance of the selection signal is Tajima’s 𝐷
[40], which is expected to be negative, in the first case, and
positive, in the second case. Tajima’s 𝐷 values estimated on
the examples given above are all positive and significant (in
both populations and at all loci, but to be confirmed when
synonymous substitutions are also taken into account). This
agrees a priori with an effect of balancing selection at all loci
and in both populations. However, this balancing selection
would not have been strong enough to erase the signals
of demography, as suggested by the very distinct shapes of
the mismatch distributions obtained for the Uyghur and the
Ami. Although the interpretation of mismatch profiles may
be more challenging in case of high rates of recombination
or gene conversion, this example emphasizes the interest of
using HLA sequences in a coalescent approach.
3.4. Taking into Account LinkageDisequilibriumandVariation
at Noncoding Regions. HLA sequencing can be used, along
with other analytical tools, to infer phased data (either at
the level of SNPs within a locus or among loci), allowing
us to better estimate linkage disequilibrium. The assessment
of linkage disequilibrium as a whole is most useful to infer
population history and demography (see, e.g., [62]). Indeed,
LD is expected to decrease with time through recombination
and thus to be low in populations of remote ancestry; in
agreement with this prediction, lower LD has been found in
an African population compared to a European, a Chinese,
and a Japanese population [63] based on a SNP haplotype
map of the extended HLA region (7,5Mb). This is congruent
with genome-wide studies (e.g., [64]). On the other hand,
LD is mainly generated by genetic drift which occurs very
fast in small and isolated populations; such populations are
therefore more prone to exhibit regions in strong LD.
Although being functionally important and hence likely
to be submitted to significant selection, DNA variability at
noncoding regulatory regions might also be informative for
the reconstruction of human evolution. Indeed, population
differences in these regions could correspond to signatures of
adaptations to peculiar environments during human evolu-
tion, for example, characterized by distinct pathogen richness
or prevalence, climates, food resources, and others. These
kinds of associations might be assessed through functional
studies and an interdisciplinary approach involving very
distinct domains such as epidemiology and archaeology.
3.5. Reconstructing Human Peopling History through Com-
puter Simulations. As several evolutionary forces govern
simultaneously the evolution of the HLA polymorphism,
demographic events can be inferred fromDNAsequence data
as long as one also takes into account the effect of selection,
and vice versa. Several methods have been developed in this
perspective (e.g., [65, 66]), but one of the most widely used
today is computer simulation of plausible scenarios for
human peopling history coupled with approaches allowing
the estimation of several kinds of parameters at the same
time (e.g., [67]). Two studies have already applied this
approach to HLA data to explore different scenarios of peo-
pling history, that is, for the Western Mediterranean region
[22] and for East Asia [68]. Both demographic parameters
(population density, demographic growth, and migration)
and balancing selection coefficients on several HLA loci
have been estimated, leading to relative selection intensities
consistent with previous studies [69, 70]. Using this kind of
methods on HLA sequence (instead of allele frequency) data
is even more promising, as it provides estimates for addi-
tional parameters, in particular those related to molecular
evolution likemolecular diversity,mutation rates, and linkage
disequilibrium (M. Currat, personal communication, 2014).
HLA sequencing thus opens many new ways of exploring
population variability in the context of both human peopling
history and molecular evolution.
4. Using HLA Molecular Variation to
Assess Regulatory Functions and Diseases
The exponential increase of genomic data has deeply influ-
encedhuman genetics andhas also influenced theway genetic
variation in HLA genes is analyzed and interpreted. In this
section, we discuss how the use of genotyping arrays and
whole genome sequencing have been incorporated into the
analysis of HLA variation. We also address the challenges in
using next generation sequencing to make inferences about
the expression of HLA genes.
4.1. SNPs in the HLA Region and GWAS Studies. Over the last
decade, the development of technologies allowing the geno-
typing of thousands of markers throughout the genome has
bolstered the implementation of genome-wide association
studies (GWAS), which are designed to search the genome
for genetic variants whose presence is statistically correlated
with a disease phenotype. The scale of GWAS has grown
dramatically, both in terms of genome coverage and sample
sizes, and it has become possible to implement investigations
with up to thousands of samples surveyed in over millions
of SNPs (e.g., Welcome Trust Case Control Consortium,
2007). The large sample sizes play an important role, given
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that there is relatively low power to detect genetic variants
that contribute to disease risk. The large number of SNPs
is likewise important, since it allows researchers to narrow
down the region which contains variants associated with the
phenotype of interest.
Various GWAS have identified SNPs that lie within the
MHC region, or within HLA genes themselves, as being
statistically associated with disease phenotypes. Overall,
whereas the MHC region makes up only 0.3% of the genome,
a catalog of genome-wide significant SNPs identifies that
6.4% are in the MHC [71], showing a marked overrepresen-
tation of variants contributing to the studied phenotypes in
this region.
The range of disease phenotypes that show associations
with genetic variants within the MHC is vast (reviewed in
[13]), spanning autoimmune disorders (e.g., type 1 diabetes,
rheumatoid arthritis, and psoriasis), response to infections
(e.g., outcome of infection by dengue, HTLV-1, HIV), neu-
ropsychiatric disorders (e.g., narcolepsy, schizophrenia), and
specific forms of cancer (e.g., Hodgkin’s lymphoma).
The finding of an association between a SNP and a disease
phenotype raises important challenges. First, it is desirable
to establish whether that genetic variant is tagging a poly-
morphism that contributes to the phenotype, or whether it
is causally related to the phenotype. Secondly, the finding
of an initial strong association in a GWAS may make the
identification of subsequent weaker yet statistically and bio-
logically relevant associations harder to find, calling for
methods which sequentially remove detected associations to
facilitate the identification of weaker ones. In the case of
associations of SNPswithin theMHCregion, these challenges
are particularly relevant given the extensive LD and high gene
density, implying that causal and noncausal variants are likely
to cosegregate (i.e., be in complete or very high LD) and that
multiple genetic variants contributing to a disease phenotype
may be localized close to one another, making it challenging
to unravel their specific roles.
Analyzing variation in the MHC in the context of
genome-wide association studies has allowed some of these
challenges to be tackled. First, the large number of SNPs
allows additional targets within the MHC region to be iden-
tified, often revealing loci that were not postulated as can-
didates. Secondly, the simultaneous analysis of SNPs in the
MHC region and elsewhere allows the effect sizes (a measure
of the degree to which genetic variation at that locus explains
variation in the phenotype of interest) to be estimated. In
this way, the relative contribution of genetic variation atHLA
and non-HLA loci can be compared. Such approaches have
shown cases where HLA genes explain the vast majority of
phenotypic variation (e.g., ankylosing spondylitis) as well as
those where non-HLA contributions can involve several loci
(e.g., rheumatoid arthritis).
Interestingly, the identification of GWAS markers which
are not in the MHC has required performing novel rounds of
statistical testing after SNPs from the MHC were removed or
thinned out (i.e., a single SNPwith strong association is kept),
since the presence ofmultiple strongly associated SNPS in the
MHC limits the ability to detect additional associations.
4.2. Using SNPs to Infer HLA Genotypes. Genetic data on
human populations can currently be generated by both
genotyping with microarrays, or by whole genome sequenc-
ing. Although techniques of NGS are becoming increasingly
cheaper, microarrays are still more cost effective on very
large samples, and most studies with very large samples are
based on SNP genotyping [72]. Over the last years, a powerful
technique called genotype imputation has been developed,
which allows the information from NGS studies to be used
to boost the informativeness of SNP genotyping surveys.
Imputation can be defined as the use of information on hap-
lotype variation in a reference sample, typically generated
by DNA sequencing, to make predictions of genotypes in
a study sample, which was genotyped at only a subset of
these SNPs. Imputation approaches effectively allow DNA
sequence data to be obtained using statistical approach and
have been shown to increase the power of GWAS [73] by
increasing the number of variants available.
Recently, several research groups have proposed that
imputation methods can be extended to the HLA genes.
The logic here is the same as for genome-wide imputation
studies: prior knowledge on the association between SNPs
in a genomic region (in this case, the MHC) and specific
haplotypes (in this case, theHLA alleles present) allowsHLA
genotypes to be inferred for individuals that were not typed
or sequenced at these loci but that have genome-wide SNP
data (which encompasses the MHC region). In the context
of the theme of the present review, these HLA imputation
methods can be seen as a way to tap into the rich resource of
contemporary genomic data and generate information which
approximates that of direct NGS of HLA genes, but relying
on an inferential approach. Although not directly comparable
to the direct sequencing of HLA alleles, these imputation
approaches do enhance the power of association studies in
the MHC region as will be discussed below.
One class of HLA imputation approaches simply extends
the logic of SNP tagging to the context of HLA genes (e.g.,
[63]), but the extremely high polymorphism of HLA genes
results in an inefficient performance. A second approach
consists in using the haplotype structure of the SNPs sur-
rounding an HLA locus to make a prediction of what HLA
alleles an individual carries [74, 75]. This latter approach
relies on the availability of a training set (i.e., a sample for
which HLA and SNP data are known and phased), as well
as phased data for the SNPs which will be used to infer the
HLA allele. Another approach circumvents the need for a
priori haplotype information concerningHLA and SNPs and
is implemented in HIBAG [76].
These methods have shown some promising results, with
imputation accuracies above 90% for common second field
level alleles in samples of Europeans typed for a set of 191 SNPs
in the MHC region [76]. However, such a high imputation
success has also been challenged [77].
The possibility of using large datasets for which SNP
genotypes are available to infer the HLA alleles is attractive
on several grounds. First, it allows existing genetic data,
often generated without the goal of characterizing HLA
variation, to be used to gain a better understanding of these
genes. Secondly, it implicitly allows the imputation of genetic
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variation at a highmolecular level of resolution. For example,
the inference of a second-field level HLA allele implies that
amino acid residues at specific positions can be inferred and
have their effects tested upon phenotypes of interest. Because
there is a priori evidence that the variation at specific amino
acids can contribute in a statistically significant way to disease
phenotypes, obtaining data at this level of resolution is an
importantmethodological resource aswill be discussed in the
next section.
Although imputation approaches may be powerful in
inferring the frequencies of common variants, critical to
GWAS studies, they are not as useful in uncovering the con-
tributions of rare variants, which by definition are difficult
to impute, given their low frequency in reference panels.
For these, direct sequencing of the HLA genes remains the
necessary strategy. In this context, it is important to consider
challenges associated with HLA genotyping in the context
of NGS. While specific protocols are being generated for
HLA genotyping based on NGS (e.g., [78]), it is clear that
features of the HLA genes make genetic analyses particularly
challenging. First, the extensive similarity among paralogous
genes results in many reads mapping to multiple loci, a
feature that in practice leads them to be discarded by aligners.
In addition, when NGS reads are mapped to the reference
human genome, many reads are discarded because they show
manymismatches with the sequences present in the reference
(an expected finding, given the high polymorphism of the
region). These two features of sequencing analyses in the
HLA region imply that conventional analysis pipelines end
up discarding a large proportion of reads (due to multiple
mappings or to extensive mismatches), resulting in loss of
information for SNPs in the HLA genes. In line with this,
Major et al. [79] have shown that high coverage data is essen-
tial in order to make correct inferences aboutHLA genotypes
based onNGS.This implies that customized proceduresmust
be implemented in order to efficiently genotype SNPs in the
HLA.
The analysis of HLA genes will benefit greatly from the
use of NGS data, since the discovery of variants via NGS
will allow imputation-based analyses to take into account
an increasingly extensive set of SNPs, including regulatory
and intronic variants. The inclusion of these variants into
association studies will be an important development, since
many play an important role in disease association and can
have their effects assessed experimentally (e.g. for regulatory
variants).
4.3. Dissecting Associations within the MHC Region. For
many diseases, candidate gene approaches had previously
shown the association of specific HLA alleles with a disease
phenotype. However, it often remained unclear if the asso-
ciation was causal or if the HLA locus was simply tagging
a causal variant, and if further genes in the MHC region
were associated with the disease phenotype. In addition,
the identification of specific amino acids within the HLA
locus contributing to the disease phenotype remained a
challenge, although hypotheses had been raised regarding
specific motifs (shared epitopes) whose presence contributed
to the disease phenotype.
The availability of large numbers of SNPs and samples
has allowed researchers to disentangle the contribution of
different markers within the MHC region to search for novel
variants and to identify molecular-level variants contributing
to the disease phenotype [71, 80].
A good example of how the contribution of multiple
loci was disentangled comes from a GWAS for Sjo¨gren’s
syndrome, which initially detected multiple SNPs within the
HLA region as associated with the disease [81]. Using logistic
regression, a technique that allows the influence of one
marker to be accounted when testing for that of another, two
independent effects were detected. A further analysis con-
sisted in imputing HLA alleles, allowing the GWAS findings
to be compared to those of previous candidate gene studies,
which focused onHLA loci. In the case of Sjo¨gren’s syndrome,
the HLA alleles previously associated with the disease were
confirmed, but the GWAS framework allowed SNPs and
HLA alleles associated with a phenotype to have their effects
disentangled, in this case showing that a GWAS SNP was a
better marker for the phenotype than the associated HLA
allele.
The GWAS framework also allows functional hypotheses
underlying associations to be probed. One way to do this
consists in testing if the set of SNPs which show associations
with the disease shows enrichment for some specific genomic
feature (e.g., regulation-related motifs, structural variation).
In the case of Sjo¨gren’s syndrome, significantly associated
SNPs showed a large excess of localization in transcription
factor binding sites [81].
A particularly fine dissection of the contribution of
variants was achieved in a study of rheumatoid arthritis,
where imputedHLA alleles were used to predict the genotype
at specific amino acid positions in a very large sample (5,018
cases and 14,974 controls) [82]. Such a large dataset allowed
associations at themolecular level to be tested, and five amino
acid positions were detected as independently contributing
to disease risk: 3 from DRB1, one from HLA-B, and one
from DPB1. Such a study exemplifies that large sample sizes,
associated with genome-wide typing and imputation ofHLA
alleles, allow the dissection of the genetic basis of a complex
disease phenotype, identifying the independent contribution
of multiple loci and specific sites within the MHC region.
4.4. Unraveling the Expression Patterns of HLA Loci. In addi-
tion to the coding variation within the gene itself, variation
in the expression level of HLA genes may also result in
important phenotypic differences related to disease status or
survival probability. It is therefore of interest to understand
how HLA expression varies and to gain insight into what are
the genetic variants that control it.
Quantifying gene expression has typically been accom-
plished by using techniques that estimate the abundance of
RNA molecules originating from a locus, and microarrays
have been employed to this end. In the case of HLA genes,
however, an important limitation arises because of the high
polymorphism of the genes, which may cause transcripts to
fail to hybridize to the probe, assuming they span a region that
is polymorphic. In light of this, expression data forHLA genes
obtained from commercial arrays is of limited reliability.
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Solutions to these problems have been to filter out results
associated with probes that match regions which are found to
be polymorphic in population level sequencing studies and
to design custom arrays that account for the known poly-
morphism [83]. Analyses that used these strategies have shed
light on important aspects of MHC region expression. First,
cell lines homozygous for distinct MHC haplotypes were
shown to have marked differences in expression, suggesting
that a haplotype-specific expression profile exists. Secondly,
genetic variants which are correlatedwith expression patterns
(known as expression QTLs, or eQTLs) were shown to
be overrepresented in the MHC region, providing a useful
list of putative regulatory variants [83]. The limitations of
these studies include the fact that samples do not typically
account for geographic variation (with the two cited studies
focusing on individuals of European ancestry) and the fact
that expression patterns of cell lines homozygous for the
MHC may not capture the full spectrum of variation in
this genomic region, calling for broader population-based
studies.
The analysis of eQTLs has also proved useful in inter-
preting GWAS results. Nica et al. [84] showed that eQTLs
are abundant among GWAS SNPs, consistent with their reg-
ulatory role contributing to disease phenotype.This rationale
can be extended to the MHC, and Lessard et al. [81] showed
that SNPs in the MHC associated with Sjo¨gren’s syndrome
are frequently eQTLs, again indicating that polymorphisms
affecting transcription levels may explain associations. These
studies indicate that over the next years we should expect
a tighter integration between data on genotypic variation
within and around HLA genes and that of phenotypic
variation, in the form of expression patterns. However, the
challenge of developing methods that can estimate HLA
expression reliably, in particular from RNAseq assays, which
are highly challenging to perform in such a polymorphic
region, remains to be addressed [85].
5. Conclusion
By entering this new genomic era characterized by high
throughput sequencing,HLAmay in someway be regarded as
an ideal polymorphism for population geneticists interested
by human diversity and evolution. Indeed, a very wide range
of issues can be addressed through its finemolecular analysis,
fromquestions related to humanpeopling history and natural
selection to the identification of markers involved in diseases
and regulatory functions. However, one should also be aware
of the potential loss of statistical power if these extraordinary
large amounts of new genetic data are not analyzed with
a correspondingly huge increase of sample sizes: then any
conclusion drawn from these studies may be as insignificant
as any other result occurring by chance.
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